CFG
Cooper Financial Group’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,367
| Closed | -$789K | – | 397 |
|
|
2025
Q1 | $789K | Buy |
11,367
+295
| +3% | +$20.5K | 0.1% | 172 |
|
|
2024
Q4 | $952K | Buy |
11,072
+593
| +6% | +$51K | 0.11% | 149 |
|
|
2024
Q3 | $1.25M | Buy |
10,479
+507
| +5% | +$60.4K | 0.16% | 108 |
|
|
2024
Q2 | $1.42M | Sell |
9,972
-1,470
| -13% | -$210K | 0.21% | 88 |
|
|
2024
Q1 | $1.47M | Buy |
11,442
+211
| +2% | +$27.1K | 0.24% | 85 |
|
|
2023
Q4 | $1.16M | Buy |
11,231
+89
| +0.8% | +$9.21K | 0.21% | 93 |
|
|
2023
Q3 | $1.01M | Buy |
11,142
+5,947
| +114% | +$541K | 0.24% | 100 |
|
|
2023
Q2 | $841K | Buy |
5,195
+3,153
| +154% | +$510K | 0.21% | 114 |
|
|
2023
Q1 | $325K | Buy |
+2,042
| New | +$325K | 0.09% | 234 |
|